Thyroid Cancers | Clinical

Multiple Agents Prove Useful in RET-Mutated Thyroid Cancer

June 24, 2021

Many options are available for the treatment of RET-mutated thyroid cancer. During a Targeted Oncology Case-Based Roundtable event, Francis Paul Worden, MD, discussed the case of a 58-year-old patients who first presented with solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue.